QWM
EW icon

Quaker Wealth Management’s Edwards Lifesciences EW Stock Holding History

Quaker Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-611
Closed -$44.3K – 1146
2025
Q1 		$44.3K Buy
+611
New +$43.7K 0.02% 165

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Quaker Wealth Management's EW Position: Q2 2026 in Review

Quaker Wealth Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 619 shares worth $56K. The position accounts for 0.02% of the portfolio, ranked #157.

Quaker Wealth Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Quaker Wealth Management held 619 shares of Edwards Lifesciences worth $56K as of Q2 2026.
  • Quaker Wealth Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Quaker Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Quaker Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.